Melvin Lathara

Medicine · Health Sciences

9h-index176citations22works1.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(12), Gene expression and cancer classification(4), Renal and related cancers(4), Cancer Genomics and Diagnostics(3), Cell Adhesion Molecules Research(2)

Publications22 total

Toward Deploying a Deep Learning Model for Diagnosis of Rhabdomyosarcoma
Modern Pathology·2024· 1 citedOpen Access
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma
British Journal of Cancer·2023· 4 citedOpen Access
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1
Biochemical and Biophysical Research Communications·2022· 5 cited
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology
Clinical and Translational Medicine·2022· 12 citedOpen Access
Correction to: Machine learning for rhabdomyosarcoma histopathology
Modern Pathology·2022· 4 cited
Machine learning for rhabdomyosarcoma histopathology
Modern Pathology·2022· 27 cited
Advancing Clinical Cohort Selection with Genomics Analysis on a Distributed Platform
2021Open Access
Bromodomain 4 inhibition leads to <i>MYCN</i> downregulation in Wilms tumor
Pediatric Blood & Cancer·2021· 14 citedOpen Access
Metastatic pediatric sclerosing epithelioid fibrosarcoma
Molecular Case Studies·2021· 12 citedOpen Access
Defining the Extracellular Matrix of Rhabdomyosarcoma
Frontiers in Oncology·2021· 17 citedOpen Access
Refractory alveolar rhabdomyosarcoma in an 11-year-old male
Molecular Case Studies·2021· 3 citedOpen Access
Bromodomain 4 inhibition leads to <i>MYCN</i> downregulation in Wilms’ tumor cells
2021Open Access
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
2020Open Access
Defining the Extracellular Matrix of Rhabdomyosarcoma
Research Square (Research Square)·2020· 1 citedOpen Access
Advancing clinical cohort selection with genomics analysis on a distributed platform
PLoS ONE·2020· 3 citedOpen Access
Defining an embryonal rhabdomyosarcoma endotype
Molecular Case Studies·2020· 10 citedOpen Access
In vitro benchmarking of NF-κB inhibitors
European Journal of Pharmacology·2020· 14 citedOpen Access
Advancing clinical cohort selection with genomics analysis on a distributed platform
Figshare·2020Open Access
Advancing clinical cohort selection with genomics analysis on a distributed platform
2019Open Access
Volasertib preclinical activity in high-risk hepatoblastoma
Oncotarget·2019· 30 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Charles Keller(16), Noah Berlow(14), Ganapati Srinivasa(14), Andrew D. Woods(8), Erin R. Rudzinski(7), Hollis Wright(7), Narendra Bharathy(6), Kevin Matlock(5), Reshma Purohit(5), Megan M. Cleary(5), Jaclyn Smith(5), Christopher T. Denny(5), Teagan P. Settelmeyer(4), Paul H. Huang(4), Robin L. Jones(4), Atiya Mansoor(4), Nalini Ganapati(4), Cora A. Ricker(3), Arthur O. Frankel(3), Agnieszka Woźniak(3)